Literature DB >> 8769920

The impact and consequences of hip fracture in Ontario.

S B Jaglal1, P G Sherry, J Schatzker.   

Abstract

OBJECTIVES: To assess the magnitude and the burden of hip fracture on the health care system, including time trends in hip fracture rates, in-hospital death rates, length of hospital stay (LHS) and discharge destination.
DESIGN: A retrospective study of discharge abstracts.
SETTING: The Province of Ontario. PATIENTS: All patients (n = 93,660) over the age of 50 years and with a diagnosis of hip fracture discharged from hospital between 1981 and 1992 (excluding transfers). MAIN OUTCOME MEASURES: Age-sex standardized hip fracture rates per 1000 population, in-hospital death rates and age-adjusted mean LHS.
RESULTS: The overall hip fracture rate was 3.3 per 1000 persons (1.7 per 1000 men and 4.6 per 1000 women). There was no change in rates between 1981 and 1992 (p = 0.089), but there have been increases in the numbers of hip fractures. There was no change in the in-hospital death rate over time (p = 0.78). The age-adjusted mean LHS in 1981 was 28.6 days compared with 22.2 days in 1992. The numbers of hip fractures will increase from 8490 in 1990 to 16 963 in 2010.
CONCLUSIONS: Despite stable age-adjusted rates of hip fractures, the doubling of the number of hip fractures by the year 2010 due to an aging population will become an increasing burden on the health care system.

Entities:  

Mesh:

Year:  1996        PMID: 8769920      PMCID: PMC3949847     

Source DB:  PubMed          Journal:  Can J Surg        ISSN: 0008-428X            Impact factor:   2.089


  24 in total

1.  Risk factors for hip fracture in older home care clients.

Authors:  Paul Stolee; Jeff Poss; Richard J Cook; Kerry Byrne; John P Hirdes
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2009-02-05       Impact factor: 6.053

Review 2.  Geographic trends in incidence of hip fractures: a comprehensive literature review.

Authors:  S Y Cheng; A R Levy; K A Lefaivre; P Guy; L Kuramoto; B Sobolev
Journal:  Osteoporos Int       Date:  2011-04-12       Impact factor: 4.507

3.  Current and projected rates of hip fracture in Canada.

Authors:  E A Papadimitropoulos; P C Coyte; R G Josse; C E Greenwood
Journal:  CMAJ       Date:  1997-11-15       Impact factor: 8.262

4.  Fracture prediction and calibration of a Canadian FRAX® tool: a population-based report from CaMos.

Authors:  L-A Fraser; L Langsetmo; C Berger; G Ioannidis; D Goltzman; J D Adachi; A Papaioannou; R Josse; C S Kovacs; W P Olszynski; T Towheed; D A Hanley; S M Kaiser; J Prior; S Jamal; N Kreiger; J P Brown; H Johansson; A Oden; E McCloskey; J A Kanis; W D Leslie
Journal:  Osteoporos Int       Date:  2010-12-16       Impact factor: 4.507

5.  Osteoporosis management in long-term care. Survey of Ontario physicians.

Authors:  H G McKercher; R G Crilly; M Kloseck
Journal:  Can Fam Physician       Date:  2000-11       Impact factor: 3.275

6.  Secular trends of hip fractures in Québec, Canada.

Authors:  A Vanasse; M G Orzanco; P Dagenais; T Ouarda; J Courteau; S Asghari; F Chebana; B Martel; P Gosselin
Journal:  Osteoporos Int       Date:  2011-08-30       Impact factor: 4.507

7.  Development and validation of the Osteoporosis Risk Assessment Instrument to facilitate selection of women for bone densitometry.

Authors:  S M Cadarette; S B Jaglal; N Kreiger; W J McIsaac; G A Darlington; J V Tu
Journal:  CMAJ       Date:  2000-05-02       Impact factor: 8.262

8.  Length of stay, wait time to surgery and 30-day mortality for patients with hip fractures after the opening of a dedicated orthopedic weekend trauma room.

Authors:  Michel Taylor; Wilma Hopman; Jeff Yach
Journal:  Can J Surg       Date:  2016-09       Impact factor: 2.089

9.  Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2006-11-01

10.  Osteoporosis screening for men: are family physicians following the guidelines?

Authors:  Natalie Cheng; Michael E Green
Journal:  Can Fam Physician       Date:  2008-08       Impact factor: 3.275

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.